Apollo Therapeutics Secures $226.5 Million in Funding for Medical Research

Apollo Therapeutics, a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines, today announced $226.5 million (£180.4 million) in Series C financing.In 2022, King’s entered a collaboration with Apollo T

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,London ,City Of ,Richard Mason ,University College London ,Imperial College London ,University Of Cambridge ,Institute Of Cancer Research ,Apollo Therapeutics ,Apollo Therapeutic ,Chief Executive Officer ,